• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

整合血浆蛋白质组学和单细胞免疫信号网络特征可区分轻症、中症和重症 COVID-19。

Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19.

机构信息

Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Stanford, CA, USA.

Section Pediatric Infectious Diseases, Laboratory of Medical Immunology, Radboud Institute for Molecular Life Sciences, Nijmegen, the Netherlands; Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, the Netherlands; Center for Molecular and Biomolecular Informatics, Radboud University Medical Center, Nijmegen, the Netherlands.

出版信息

Cell Rep Med. 2022 Jul 19;3(7):100680. doi: 10.1016/j.xcrm.2022.100680. Epub 2022 Jun 28.

DOI:10.1016/j.xcrm.2022.100680
PMID:35839768
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9238057/
Abstract

The biological determinants underlying the range of coronavirus 2019 (COVID-19) clinical manifestations are not fully understood. Here, over 1,400 plasma proteins and 2,600 single-cell immune features comprising cell phenotype, endogenous signaling activity, and signaling responses to inflammatory ligands are cross-sectionally assessed in peripheral blood from 97 patients with mild, moderate, and severe COVID-19 and 40 uninfected patients. Using an integrated computational approach to analyze the combined plasma and single-cell proteomic data, we identify and independently validate a multi-variate model classifying COVID-19 severity (multi-class area under the curve [AUC] = 0.799, p = 4.2e-6; multi-class AUC = 0.773, p = 7.7e-6). Examination of informative model features reveals biological signatures of COVID-19 severity, including the dysregulation of JAK/STAT, MAPK/mTOR, and nuclear factor κB (NF-κB) immune signaling networks in addition to recapitulating known hallmarks of COVID-19. These results provide a set of early determinants of COVID-19 severity that may point to therapeutic targets for prevention and/or treatment of COVID-19 progression.

摘要

导致 2019 年冠状病毒(COVID-19)临床表现范围的生物学决定因素尚未完全阐明。在这里,我们对 97 名轻度、中度和重度 COVID-19 患者以及 40 名未感染患者的外周血进行了横断面评估,涉及超过 1400 种血浆蛋白和 2600 种单细胞免疫特征,包括细胞表型、内源性信号活性以及对炎症配体的信号反应。通过综合计算方法分析联合血浆和单细胞蛋白质组学数据,我们鉴定并独立验证了一种多变量模型,用于分类 COVID-19 严重程度(多类 AUC = 0.799,p = 4.2e-6;多类 AUC = 0.773,p = 7.7e-6)。对有意义的模型特征的检查揭示了 COVID-19 严重程度的生物学特征,包括 JAK/STAT、MAPK/mTOR 和核因子κB(NF-κB)免疫信号网络的失调,此外还重现了 COVID-19 的已知特征。这些结果提供了一组 COVID-19 严重程度的早期决定因素,这些因素可能指向 COVID-19 进展的预防和/或治疗的治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d73c/9381417/c54c1d070946/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d73c/9381417/ec23bf3fafde/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d73c/9381417/b31248563a12/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d73c/9381417/6b3991f3b148/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d73c/9381417/0eb087f5b790/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d73c/9381417/c54c1d070946/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d73c/9381417/ec23bf3fafde/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d73c/9381417/b31248563a12/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d73c/9381417/6b3991f3b148/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d73c/9381417/0eb087f5b790/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d73c/9381417/c54c1d070946/gr4.jpg

相似文献

1
Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19.整合血浆蛋白质组学和单细胞免疫信号网络特征可区分轻症、中症和重症 COVID-19。
Cell Rep Med. 2022 Jul 19;3(7):100680. doi: 10.1016/j.xcrm.2022.100680. Epub 2022 Jun 28.
2
Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19.整合血浆蛋白质组学和单细胞免疫信号网络特征可区分轻度、中度和重度新冠肺炎。
bioRxiv. 2021 Feb 10:2021.02.09.430269. doi: 10.1101/2021.02.09.430269.
3
Pathological features of COVID-19-associated lung injury: a preliminary proteomics report based on clinical samples.基于临床样本的 COVID-19 相关肺损伤的病理特征:初步蛋白质组学报告。
Signal Transduct Target Ther. 2020 Oct 15;5(1):240. doi: 10.1038/s41392-020-00355-9.
4
The Role of the Nuclear Factor-Kappa B (NF-κB) Pathway in SARS-CoV-2 Infection.核因子-κB(NF-κB)信号通路在严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染中的作用
Pathogens. 2024 Feb 12;13(2):164. doi: 10.3390/pathogens13020164.
5
Phillyrin (KD-1) exerts anti-viral and anti-inflammatory activities against novel coronavirus (SARS-CoV-2) and human coronavirus 229E (HCoV-229E) by suppressing the nuclear factor kappa B (NF-κB) signaling pathway.汉防己甲素(KD-1)通过抑制核因子 kappa B(NF-κB)信号通路,对新型冠状病毒(SARS-CoV-2)和人类冠状病毒 229E(HCoV-229E)发挥抗病毒和抗炎作用。
Phytomedicine. 2020 Nov;78:153296. doi: 10.1016/j.phymed.2020.153296. Epub 2020 Aug 1.
6
Multi-omic profiling reveals widespread dysregulation of innate immunity and hematopoiesis in COVID-19.多组学分析揭示 COVID-19 中固有免疫和造血作用的广泛失调。
J Exp Med. 2021 Aug 2;218(8). doi: 10.1084/jem.20210582. Epub 2021 Jun 15.
7
Cardiovascular Risk After SARS-CoV-2 Infection Is Mediated by IL18/IL18R1/HIF-1 Signaling Pathway Axis.新冠病毒感染后心血管风险是由 IL18/IL18R1/HIF-1 信号通路轴介导的。
Front Immunol. 2022 Jan 5;12:780804. doi: 10.3389/fimmu.2021.780804. eCollection 2021.
8
SARS-CoV-2 Nsp14 protein associates with IMPDH2 and activates NF-κB signaling.SARS-CoV-2 Nsp14 蛋白与 IMPDH2 结合并激活 NF-κB 信号通路。
Front Immunol. 2022 Sep 13;13:1007089. doi: 10.3389/fimmu.2022.1007089. eCollection 2022.
9
The Role of Nuclear Factor Kappa B (NF-κB) in Development and Treatment of COVID-19: Review.核因子-κB(NF-κB)在 COVID-19 发生发展及治疗中的作用:综述
Int J Mol Sci. 2022 May 9;23(9):5283. doi: 10.3390/ijms23095283.
10
Yindan Jiedu granules exhibit anti-inflammatory effect in patients with novel Coronavirus disease (COVID-19) by suppressing the NF-κB signaling pathway.银丹解毒颗粒通过抑制 NF-κB 信号通路对新型冠状病毒病(COVID-19)患者发挥抗炎作用。
Phytomedicine. 2022 Jan;95:153784. doi: 10.1016/j.phymed.2021.153784. Epub 2021 Oct 1.

引用本文的文献

1
Distinct proteomic signatures in Ethiopians predict acute and long-term sequelae of COVID-19.埃塞俄比亚人的独特蛋白质组学特征可预测新冠病毒病的急性和长期后遗症。
Front Immunol. 2025 May 22;16:1575135. doi: 10.3389/fimmu.2025.1575135. eCollection 2025.
2
APNet, an explainable sparse deep learning model to discover differentially active drivers of severe COVID-19.APNet,一种可解释的稀疏深度学习模型,用于发现重症新冠肺炎的差异活跃驱动因素。
Bioinformatics. 2025 Mar 4;41(3). doi: 10.1093/bioinformatics/btaf063.
3
Delineating sex-specific circulating host response signatures associated with COVID-19 severity and mortality.
描绘与COVID-19严重程度和死亡率相关的性别特异性循环宿主反应特征。
iScience. 2024 Oct 11;27(11):111150. doi: 10.1016/j.isci.2024.111150. eCollection 2024 Nov 15.
4
An immune signature of postoperative cognitive decline: a prospective cohort study.术后认知功能下降的免疫特征:一项前瞻性队列研究。
Int J Surg. 2024 Dec 1;110(12):7749-7762. doi: 10.1097/JS9.0000000000002118.
5
Extracellular matrix remodelling pathway in peripheral blood mononuclear cells from severe COVID-19 patients: an explorative study.严重 COVID-19 患者外周血单个核细胞细胞外基质重塑途径:一项探索性研究。
Front Immunol. 2024 Jun 18;15:1379570. doi: 10.3389/fimmu.2024.1379570. eCollection 2024.
6
A generalizable and easy-to-use COVID-19 stratification model for the next pandemic via immune-phenotyping and machine learning.通过免疫表型和机器学习为下一次大流行建立一种可推广且易于使用的 COVID-19 分层模型。
Front Immunol. 2024 Mar 27;15:1372539. doi: 10.3389/fimmu.2024.1372539. eCollection 2024.
7
Multi-omics Investigations in Endocrine Systems and Their Clinical Implications.多组学在内分泌系统中的研究及其临床意义。
Adv Exp Med Biol. 2024;1443:187-209. doi: 10.1007/978-3-031-50624-6_10.
8
Kinome and phosphoproteome reprogramming underlies the aberrant immune responses in critically ill COVID-19 patients.激酶组和磷酸化蛋白质组重编程是重症 COVID-19 患者异常免疫反应的基础。
Clin Proteomics. 2024 Feb 22;21(1):13. doi: 10.1186/s12014-024-09457-w.
9
Detection of Severe Lung Infection on Chest Radiographs of COVID-19 Patients: Robustness of AI Models across Multi-Institutional Data.新型冠状病毒肺炎患者胸部X线片上严重肺部感染的检测:人工智能模型在多机构数据中的稳健性
Diagnostics (Basel). 2024 Feb 5;14(3):341. doi: 10.3390/diagnostics14030341.
10
Longitudinal plasma proteomics reveals biomarkers of alveolar-capillary barrier disruption in critically ill COVID-19 patients.纵向血浆蛋白质组学揭示了危重症COVID-19患者肺泡-毛细血管屏障破坏的生物标志物。
Nat Commun. 2024 Jan 25;15(1):744. doi: 10.1038/s41467-024-44986-w.